In the agreement, UNICEF has negotiated a price of up to US$65 per vaccine dose, the lowest price in the market. The ...

First award under UNICEF emergency tender to secure availability of mpox vaccines for Africa COPENHAGEN, Denmark, September 26, 2024 - Bavarian Nordic A/S (OMX: BAVA) today announced an agreement with ...

First award under UNICEF emergency tender to secure availability of mpox vaccines for Africa COPENHAGEN, Denmark, September ...

The vaccine bulk manufacturing is scheduled for 2025 with the delivery of the freeze-dried doses set for 2026.

Amid the rising concerns of Mpox across the globe, two studies have revealed that the efficacy of Bavarian Nordic’s vaccine, ...

Further evidence of benefit from a target trial emulation study The modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine, originally developed to protect against smallpox, was introduced in 2022 ...

Research shows that the effectiveness of Bavarian Nordic’s Mpox vaccine drops to undetectable levels after 6-12 months.

The World Health Organization (WHO) has announced the MVA-BN vaccine as the first vaccine against mpox to be added to its prequalification list. The prequalification approval is expected to facilitate ...

The escalating global Mpox outbreak has been met with a concerning revelation. Two distinct studies have indicated that the ...

With the outbreak of Mpox in several countries, the demand for vaccines has increased. The vaccine, administered as a 2-dose ...

Jolaoso described the unfounded claim of vaccines “being unsafe or a tool designed to reduce African populations” as lacking ...

Amid the rising global outbreak of Mpox, two separate studies have shown that the efficacy of Bavarian Nordic’s vaccine ...